Hemcheck Sweden AB (publ) publishes the Annual Report for 2016 - Regulatory
April 28 2017 - 3:00AM
hemCheck Publishes the
Annual Report for 2016 - Regulatory
This Press Release should not be
released or distributed, directly or indirectly, within USA,
Canada, Japan, Australia, Hong Kong, Switzerland, Singapore, South
Africa, New Zealand or any other jurisdictions where distribution
would be subject to legal restrictions.
Hemcheck Sweden AB (publ)
announces today that the company publishes the annual report for
2016. The annual report is available in Swedish on the company's
website www.hemcheck.com and via the attached PDF.
About hemCheck:
Hemcheck Sweden is a medical technology company
addressing the issue of hemolysis (the rupturing of red blood
cells) - the most common reason for blood samples to be deemed
unfit for laboratory analysis. Hemcheck Sweden is doing this by
developing and commercializing a novel product concept (HELGE(TM)
and READY(TM)) that detects hemolyzed blood samples at the point of
care. Hemcheck Sweden was founded in 2010 and is headquartered in
Karlstad, Sweden.
Contact
hemCheck Sweden AB (publ)
Annelie Brolinson, CEO
Tel: +46 70 288 0826
E-post: annelie.brolinson@hemcheck.com
Universitetsgatan 2
651 88 Karlstad
www.hemcheck.com
Important information
This is information which hemCheck is required to
disclose according to EU Market Abuse Regulation law. The
information was provided by the above contact person's auspices,
for publication on 28th of April
2017, 09:00.
Annual Report 2016
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Hemcheck Sweden AB via Globenewswire
Hsbc Msci Em Ac (LSE:HEMC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Hsbc Msci Em Ac (LSE:HEMC)
Historical Stock Chart
From Apr 2023 to Apr 2024
